Medicare-Negotiated Drugs May Not Get Favorable Coverage In Part D: Will CMS Intervene?

 
• By Cathy Kelly
  
A Lack Of Rebates or Discounts For Negotiated Part D Drugs Could Impact Premiums. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access